NCT06579833Active, not recruiting
Histotripsy (HistoSonics®) for Liver Tumours
Histotripsy (HistoSonics®) for Liver Tumours: a Phase II Safety and Efficacy Study
Source: ClinicalTrials.gov · Last updated 16 Dec 2025
Brief summary (registry, in English)
Histotripsy is a promising non-invasive technique that uses high-intensity ultrasound waves to disrupt tissue without damaging surrounding structures. It works by using high-intensity ultrasound waves to create microscopic bubbles within the tumour tissue. These bubbles rapidly expand and collapse, generating shock waves that disrupt the tissue. The technique is highly precise and can be targeted to specific areas of the liver, allowing for selective destruction of tumour cells while minimizing damage to healthy tissue. This study will enrol 20 patients with liver tumours (be it primary or secondary liver tumours), monitor their post-operative adverse events, and study the changes in tumour size and volume after treatment. Histotripsy will be performed under general anaesthesia, with real-time monitoring by ultrasound, and deliver high-intensity ultrasound waves in single session or multiple sessions. Similar to other minimal invasive treatments, patients will be admitted 1 day prior, then receive Histotripsy on the next day and stay overnight for observation. Patients will be discharged on the 3rd day if unremarkable. During the hospital stay, blood samplings will be taken for evaluation around 2-4 times in total depending on the length of hospital stay.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 13 Aug 2024
- Start date
- Aug 2024
- Primary completion date
- Sept 2027
- Lead sponsor
- The University of Hong Kong
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT06579833
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Aug 2024 to the primary completion date, Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Refusal to take part in clinical trial
- Child C liver cirrhosis
- Not fit for general anaesthesia
Who the study is looking for
- Fit for general anaesthesia
- Liver tumour size \< 10cm
- Solitary or multifocal
- Primary liver tumour such as hepatocellular carcinoma or intrahepatic cholangiocarcinoma
- Secondary liver tumour such as liver metastasis
- Patients with operable or inoperable liver tumours
- Liver transplant candidates awaiting for liver graft
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Hong Kong Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.